Samsung Biologics union vows appeal after court blocks planned strike

A Seoul court granted Samsung Biologics an order that prevents its labor union from holding a strike that had been scheduled for the company's bio-manufacturing campus.

The union, representing contract-development and manufacturing staff, said it will challenge the ruling and continue to organize actions to press its demands.

Analysts note that a work stoppage at the contract manufacturer could disrupt supply chains for multiple pharmaceutical clients, adding uncertainty for investors.